In summary, NLRP3 activation in ECs, contributes significantly to vascular inflammation and endothelial dysfunction, playing a crucial role in the progression of cardiovascular and inflammatory diseases such as atherosclerosis. Here, NLRP3 is linked to endothelial dysfunction.